The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year....more
1/24/2020
/ Biosimilars ,
Biotechnology ,
Bristol-Myers Squibb ,
China ,
Digital Health ,
Genetic Materials ,
Genetic Testing ,
Investment ,
Investment Opportunities ,
JPMorgan Chase ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
UK Brexit ,
US Trade Policies ,
Venture Capital
Rock Health reported that $4.2 billion was invested in digital health companies during the first half of 2019. This places the sector on pace to exceed 2018’s record total annual investment of $8.2 billion....more
No matter who is doing the counting, 2018 was an off-the-charts year for venture investment in digital health. Here’s a sampling of the tallies...more
Private investment in digital health continued apace in the second quarter of 2018, based on our latest look at deal flow. As the sector has matured, growth in investment levels quarter-over-quarter and year-over-year appears...more